ISMRM Workshop on

Translational Cancer Imaging:

From Acronym to Actuality

calendar_month

11-14 March 2026

location_on

Universidad Autónoma de Madrid (UAM)
Faculty of Medicine
Madrid, Spain

Organizers

Co-Chairs:
Ananth Madhuranthakam, Ph.D.
Pavithra Viswanth, Ph.D.

Local Co-Chair:
Jesus Pacheco-Torres, Ph.D.

Call for Abstracts & Stipend Applications

Abstract submission deadline:

Declarations & Supporters

Faculty declarations will be available approximately two weeks before the workshop begins.

Registration & Travel

Registration Information Coming Soon

Travel & Housing Information

Need a Visa Letter?
Please download and complete this self-fillable PDF letter.

For Presenters & Attendees

Program information coming soon.

Guidelines for Presenters & Posters

Sustainability

ISMRM Sustainability Initiatives

Overview & Program

Workshop Overview

The ISMRM Workshop on Translational Cancer Imaging: From Acronym to Actuality is a comprehensive two and a half-day event that aims to bridge the gap between research and clinical practice in cancer imaging. The workshop, set to take place in Madrid, Spain, will cover a wide range of topics related to the use of imaging in cancer diagnosis, treatment planning, and monitoring.

The first session will focus on physicians' perspectives on the use of imaging in patient care for various cancers, including glioblastoma, breast cancer, prostate cancer, and HCC/kidney cancer. The second session will delve into advanced MRI techniques for cancer, such as diffusion-weighted imaging (DWI), dynamic contrast-enhanced (DCE) MRI, magnetic resonance spectroscopy (MRS), and chemical exchange saturation transfer (CEST). The third and fourth sessions will explore the applications of cancer imaging, including genotyping and phenotyping, early detection, stratification, risk characterization, biomarkers for predicting and monitoring therapy response, and image-guided and adaptive therapy. Specific imaging techniques and applications, such as prostate bi-parametric screening, preclinical imaging, PET/MR, radio-genomics, MR-Linac, and intra-operative MRI, will be discussed.

The final session will focus on cancer image analysis, covering topics such as artificial intelligence (AI), machine learning, deep learning, multi-modality imaging, mathematical modeling, and omics. Throughout the workshop, attendees will have the opportunity to participate in oral presentations, poster sessions, and round table discussions, fostering collaboration and knowledge sharing among professionals from various backgrounds.

Overall, the ISMRM Workshop on Translational Cancer Imaging aims to provide a platform for radiologists, oncologists, radiation oncologists, medical physicists, imaging scientists, and researchers to discuss the latest developments, challenges, and opportunities in translational cancer imaging, ultimately working towards improving patient care and outcomes.

Educational Objectives

Upon completion of this activity, participants should be able to:

Target Audience

The target audience for the ISMRM Workshop on Translational Cancer Imaging will be a multidisciplinary group of professionals involved in cancer imaging research and clinical applications. This likely will include MR physicists, radiologists, oncologists, radiation oncologists, medical physicists, imaging scientists, and researchers working in the field of cancer imaging.

The workshop covers a wide range of topics, from physicians' perspectives on imaging in patient care to advanced MRI techniques, applications of cancer imaging, and image analysis using AI and machine learning. The diverse content aims to bring together individuals from various backgrounds to discuss and learn about the latest developments, challenges, and opportunities in translational cancer imaging.

The workshop's focus on translating imaging advances into clinical practice further indicates that it is designed for professionals interested in bridging the gap between research and patient care.

Preliminary Program

Coming Soon